Intraductal component and BRCA1-associated breast cancer [3]

Lancet

Volumn 348, Issue 9034, 1996, Pages 1098-

  Jacquemier, J ^a   Eisinger, F ^a   Guinebretiere, J M ^a   Stoppa Lyonnet, D ^a   Sobol, H ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DUCT; CANCER RECURRENCE; FEMALE; GENE LOCUS; GENE MUTATION; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029830465     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64441-8     Document Type: Letter

References (5)

1. F Eisinger D Stoppa-Lyonnet M Longy Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer Cancer Res 56 1996 471 474
2. J Marcus P Watson D Page Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage Cancer 77 1996 697 709
3. C Sun G Lenoir H Lynch S Narod In-situ breast cancer and BRCA1 Lancet 348 1996 408
4. J Jacquemier J Kurtz R Amalric H Brandone Y Ayne J-M Spitalier An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy Br J Cancer 61 1990 873 876
5. J Kurtz J Jacquemier R Amalric Why are local recurrences after breast-conservating therapy more frequent in younger patients? J Clin Oncol 8 1990 591 598